364 related articles for article (PubMed ID: 17407364)
21. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
[TBL] [Abstract][Full Text] [Related]
22. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
23. Multiplex meta-analysis of medulloblastoma expression studies with external controls.
Morgan AA; Achrol AS; Li MD; Khatri PJ; Cheshier SH
Pac Symp Biocomput; 2014; ():99-109. PubMed ID: 24297537
[TBL] [Abstract][Full Text] [Related]
24. Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies.
Wang J; Garancher A; Ramaswamy V; Wechsler-Reya RJ
Annu Rev Neurosci; 2018 Jul; 41():207-232. PubMed ID: 29641939
[TBL] [Abstract][Full Text] [Related]
25. Challenges and Recent Advances in Medulloblastoma Therapy.
Kumar V; Kumar V; McGuire T; Coulter DW; Sharp JG; Mahato RI
Trends Pharmacol Sci; 2017 Dec; 38(12):1061-1084. PubMed ID: 29061299
[TBL] [Abstract][Full Text] [Related]
26. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.
Smits M; van Rijn S; Hulleman E; Biesmans D; van Vuurden DG; Kool M; Haberler C; Aronica E; Vandertop WP; Noske DP; Würdinger T
Clin Cancer Res; 2012 Aug; 18(15):4048-58. PubMed ID: 22696229
[TBL] [Abstract][Full Text] [Related]
27. New concepts in organ site research on medulloblastoma: genetics and genomics.
Roussel MF
Future Oncol; 2010 Aug; 6(8):1229-31. PubMed ID: 20799868
[TBL] [Abstract][Full Text] [Related]
28. Identification of cell surface targets through meta-analysis of microarray data.
Haeberle H; Dudley JT; Liu JT; Butte AJ; Contag CH
Neoplasia; 2012 Jul; 14(7):666-9. PubMed ID: 22904683
[TBL] [Abstract][Full Text] [Related]
29. [Evolution of the management of pediatric and adult medulloblastoma].
Vigneron C; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Helfre S; Alapetite C; Coca A; Kehrli P; Noël G
Cancer Radiother; 2015 Aug; 19(5):347-57; quiz 358-9, 362. PubMed ID: 26141663
[TBL] [Abstract][Full Text] [Related]
30. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.
Hovestadt V; Remke M; Kool M; Pietsch T; Northcott PA; Fischer R; Cavalli FM; Ramaswamy V; Zapatka M; Reifenberger G; Rutkowski S; Schick M; Bewerunge-Hudler M; Korshunov A; Lichter P; Taylor MD; Pfister SM; Jones DT
Acta Neuropathol; 2013 Jun; 125(6):913-6. PubMed ID: 23670100
[No Abstract] [Full Text] [Related]
31. Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time.
Holgado BL; Guerreiro Stucklin A; Garzia L; Daniels C; Taylor MD
Annu Rev Genomics Hum Genet; 2017 Aug; 18():143-166. PubMed ID: 28475368
[TBL] [Abstract][Full Text] [Related]
32. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
[TBL] [Abstract][Full Text] [Related]
33. Current treatment of medulloblastoma: recent advances and future challenges.
Rood BR; Macdonald TJ; Packer RJ
Semin Oncol; 2004 Oct; 31(5):666-75. PubMed ID: 15497120
[TBL] [Abstract][Full Text] [Related]
34. Detection of lower levels of SNAP25 using multiple microarray systems and its functional significance in medulloblastoma.
Huang CJ; Lee CL; Liu CY; Huang SH; Hou JW; Chen YH; Chien CC; Ho CM; Lo WC; Hung KL
Int J Mol Med; 2017 May; 39(5):1195-1205. PubMed ID: 28339008
[TBL] [Abstract][Full Text] [Related]
35. Past, current and future protocols for combined modality therapy in childhood medulloblastoma.
Kaaijk P; Schouten-van Meeteren AY; Slotman BJ; Kaspers GJ
Expert Rev Anticancer Ther; 2003 Feb; 3(1):79-90. PubMed ID: 12597352
[TBL] [Abstract][Full Text] [Related]
36. PRAME gene expression profile in medulloblastoma.
Vulcani-Freitas TM; Saba-Silva N; Cappellano A; Cavalheiro S; Toledo SR
Arq Neuropsiquiatr; 2011 Feb; 69(1):9-12. PubMed ID: 21359415
[TBL] [Abstract][Full Text] [Related]
37. The role of chromatin remodeling in medulloblastoma.
Jones DT; Northcott PA; Kool M; Pfister SM
Brain Pathol; 2013 Mar; 23(2):193-9. PubMed ID: 23432644
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
39. [Medulloblastoma in pediatrics. Current prognosis and treatment].
Rivera-Luna R; Niembro-Zúñiga AM; Zarco A; Marhx-Bracho A; Cárdenas-Cardós R; Olaya-Vargas A; Rueda-Franco F; Martínez-Avalos A
Gac Med Mex; 2007; 143(5):415-20. PubMed ID: 18246935
[TBL] [Abstract][Full Text] [Related]
40. Genetics of medulloblastoma: clues for novel therapies.
Onvani S; Etame AB; Smith CA; Rutka JT
Expert Rev Neurother; 2010 May; 10(5):811-23. PubMed ID: 20420498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]